Open AccessInterleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline
Author(s) -
Sébastien J. Hotte,
T. Waldron,
Christina Canil,
Eric Winquist
Publication year - 2012
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.34
Subject(s) - medicine , oncology , renal cell carcinoma , nausea , alpha interferon , randomized controlled trial , progression free survival , gastroenterology , chemotherapy , interferon , immunology
We performed a systematic review of randomized controlled trials (RCTs) to assess the efficacy of interleukin-2 (IL-2) for the treatment of patients with unresectable or metastatic renal cell carcinoma (RCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom